Hazlett, Burt & Watson’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.68M Buy
18,428
+155
+0.8% +$36.1K 1.24% 9
2026
Q1
$4.46M Sell
18,273
-572
-3% -$133K 1.4% 7
2025
Q4
$3.9M Buy
18,845
+37
+0.2% +$7.32K 1.25% 10
2025
Q3
$3.49M Sell
18,808
-372
-2% -$63.7K 1.23% 12
2025
Q2
$2.93M Buy
19,180
+453
+2% +$69.6K 1.2% 12
2025
Q1
$3.1M Sell
18,727
-358
-2% -$56K 1.4% 9
2024
Q4
$2.76M Buy
19,085
+45
+0.2% +$6.97K 1.22% 11
2024
Q3
$3.08M Buy
19,040
+1,298
+7% +$207K 1.42% 9
2024
Q2
$2.59M Buy
17,742
+3,116
+21% +$463K 1.33% 11
2024
Q1
$2.32M Buy
14,626
+223
+2% +$35.5K 1.39% 11
2023
Q4
$2.26M Sell
14,403
-123
-0.8% -$18.9K 1.52% 9
2023
Q3
$2.26M Sell
14,526
-65
-0.4% -$10.7K 1.68% 9
2023
Q2
$2.42M Sell
14,591
-73
-0.5% -$11.8K 1.8% 10
2023
Q1
$2.27M Buy
14,664
+153
+1% +$24.7K 1.86% 10
2022
Q4
$2.56M Sell
14,511
-12
-0.1% -$2.07K 2.25% 6
2022
Q3
$2.37M Buy
14,523
+546
+4% +$92.4K 2.3% 7
2022
Q2
$2.49M Sell
13,977
-277
-2% -$49.4K 2.28% 6
2022
Q1
$2.52M Buy
+14,254
New +$2.43M 2% 8

Other funds holding JNJ

Hazlett, Burt & Watson's JNJ Position: Q2 2026 in Review

Hazlett, Burt & Watson increased its Johnson & Johnson (JNJ) stake by 0.85% in Q2 2026, buying an estimated $36.1K and bringing the position to 18,428 shares worth $4.68M. The position accounts for 1.24% of the portfolio, ranked #9.

Hazlett, Burt & Watson first reported a position in JNJ in Q1 2022 and has held it in 18 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Hazlett, Burt & Watson held 18,428 shares of Johnson & Johnson worth $4.68M as of Q2 2026.
  • Hazlett, Burt & Watson bought 155 Johnson & Johnson shares in Q2 2026, an estimated $36.1K.
  • Johnson & Johnson made up 1.24% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #9 holding.
  • Hazlett, Burt & Watson first reported a position in Johnson & Johnson in Q1 2022 and has held it in 18 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.